![Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. - Abstract - Europe PMC Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7500898/bin/gr1_lrg.jpg)
Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. - Abstract - Europe PMC
![Recommended clinical guideline for the management of Kawasaki disease... | Download Scientific Diagram Recommended clinical guideline for the management of Kawasaki disease... | Download Scientific Diagram](https://www.researchgate.net/profile/Robert-Tulloh-2/publication/258102812/figure/fig1/AS:202846071988228@1425373680509/Recommended-clinical-guideline-for-the-management-of-Kawasaki-disease-in-the-UK-Since_Q640.jpg)
Recommended clinical guideline for the management of Kawasaki disease... | Download Scientific Diagram
![Acetylsalicylic acid for children with Kawasaki disease | The College of Family Physicians of Canada Acetylsalicylic acid for children with Kawasaki disease | The College of Family Physicians of Canada](https://www.cfp.ca/sites/default/files/highwire/cfp/63/8.cover-source.jpg)
Acetylsalicylic acid for children with Kawasaki disease | The College of Family Physicians of Canada
![Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease | Pediatric Research Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease | Pediatric Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fpr.2018.44/MediaObjects/41390_2018_Article_BFpr201844_Fig1_HTML.jpg)
Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease | Pediatric Research
![Efficacy of the Delayed Use of Low-dose Aspirin in Intravenous Immunoglobulin Therapy for Acute-phase Kawasaki Disease | European Journal of Medical and Health Sciences Efficacy of the Delayed Use of Low-dose Aspirin in Intravenous Immunoglobulin Therapy for Acute-phase Kawasaki Disease | European Journal of Medical and Health Sciences](https://www.ejmed.org/public/journals/1/article_691_cover_en_US.jpg)
Efficacy of the Delayed Use of Low-dose Aspirin in Intravenous Immunoglobulin Therapy for Acute-phase Kawasaki Disease | European Journal of Medical and Health Sciences
![National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2341287918301406:gr2.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9/qVHBXBqbSQ7FNUvNof+6+l4v03CmyaR9Rm+q8TRfDEOS68CZK9bYY3KxU3zGztanBlteDayc3/6fH+YvoQ2fMAWIHV9b+ThkchP2KLIwTjnIUOi1XxUN79VNA04rve3lfKwLhXphPFxqAQi5bz38BHS52IUaeZvXfLy+Y/lgJub3mnMUWaqptQe9GJCKC2cU5c+8jRiK3cq88/X8Lu722aboh6ybgrjeNUpjUXH8reoOSF6viLq2xzdlyaa1UgLNaBby8I6k7v9Wd3JqSmfs14+ihwMN/YtNqt8LvGFXhW)
National consensus on the cardiological treatment and follow-up of Kawasaki disease | Anales de Pediatría
PLOS ONE: High-Dose Aspirin Is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease
![Children | Free Full-Text | The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic Children | Free Full-Text | The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic](https://www.mdpi.com/children/children-07-00185/article_deploy/html/images/children-07-00185-g001.png)
Children | Free Full-Text | The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic
![UK - Oct. 2019 - Aspirin - Acetylsalicylic Acid - England Editorial Image - Image of pharmaceutical, painkiller: 160586505 UK - Oct. 2019 - Aspirin - Acetylsalicylic Acid - England Editorial Image - Image of pharmaceutical, painkiller: 160586505](https://thumbs.dreamstime.com/z/aspirin-also-known-as-acetylsalicylic-acid-everyday-painkiller-used-to-treat-pain-fever-inflammation-specific-160586505.jpg)
UK - Oct. 2019 - Aspirin - Acetylsalicylic Acid - England Editorial Image - Image of pharmaceutical, painkiller: 160586505
![Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan | Pediatrics Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan | Pediatrics](https://www.frontiersin.org/files/MyHome%20Article%20Library/522921/522921_Thumb_400.jpg)
Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan | Pediatrics
![Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13052-021-00962-4/MediaObjects/13052_2021_962_Fig2_HTML.png)
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
![Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2FBF03262128/MediaObjects/40267_2012_2128_FigU1.jpg)
Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink
![Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes - ScienceDirect Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022347616314160-ympd8877-fig-0001.jpg)